Newly diagnosed epilepsy: Initial treatment with generics - PROS

被引：0
|
作者：
Ben-Menachem, E. [1 ]
机构：
[1] Sahlgrens Univ Hosp, Inst Clin Neurosci & Physiol, Gothenburg, Sweden
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2007年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：312 / 312
页数：1
相关论文
共 50 条
  • [21] Phenobarbital in newly diagnosed epilepsy
    Brodie, MJ
    EPILEPSIA, 2005, 46 : 29 - 29
  • [22] Epidemiology of newly diagnosed epilepsy
    Hauser, A
    EPILEPSIA, 2004, 45 : 3 - 3
  • [23] Topiramate in newly diagnosed epilepsy: 100 Mg/day as initial target dose
    Sander, JWAS
    Arroyo, S
    Privitera, M
    Squires, L
    Wang, S
    Twyman, R
    EPILEPSIA, 2003, 44 : 82 - 82
  • [24] Drug treatment in patients with newly diagnosed unprovoked seizures/epilepsy
    Karlsson, Linnea
    Wettermark, Bjorn
    Tomson, Torbjorn
    EPILEPSY RESEARCH, 2014, 108 (05) : 902 - 908
  • [25] Epilepsy: from newly diagnosed to treatment-resistant disease
    French, Jacqueline
    Friedman, Daniel
    LANCET NEUROLOGY, 2011, 10 (01): : 9 - 11
  • [26] Evaluation of quantitative EEG markers for predicting outcome after the initial treatment with levetiracetam monotherapy in newly diagnosed epilepsy
    Zahnert, Felix
    van Mierlo, Pieter
    Habermehl, Lena
    Garcia, Llenalia
    Malki, Karim
    Knake, Susanne
    EPILEPSY & BEHAVIOR, 2025, 164
  • [27] Drug treatment failures and effectivity in children with newly diagnosed epilepsy
    Arhan, Ebru
    Serdaroglu, Ayse
    Kurt, Ayse Nese Citak
    Aslanyavrusu, Memet
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2010, 19 (09): : 553 - 557
  • [28] THE EFFECTIVENESS OF USING "GENERICS" IN THE TREATMENT OF EPILEPSY
    Belyaev, O.
    Volkova, E.
    EPILEPSIA, 2014, 55 : 112 - 112
  • [29] Racial differences in initial psoriasis treatment for newly diagnosed patients
    Miller, R.
    Do, M.
    Abedian, S.
    Lipner, S.
    EXPERIMENTAL DERMATOLOGY, 2021, 30 : 22 - 22
  • [30] The choice of initial monotherapy in newly diagnosed epilepsy requires careful consideration of multiple factors
    Drugs & Therapy Perspectives, 2009, 25 (12) : 14 - 18
12345